Cite
HARVARD Citation
Carroll, H. et al. (n.d.). 358 Trial in progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC). Journal for immunotherapy of cancer. pp. A218-A219. [Online].